Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:57 AM
Ignite Modification Date: 2025-12-25 @ 12:57 AM
NCT ID: NCT01243593
Eligibility Criteria: Inclusion Criteria: * American Society of Anesthesiologists (ASA) classification score 1-3 * age 1 month to 6 years inclusive Exclusion Criteria: * children undergoing an additional surgical procedure at an anatomical location not covered by a unilateral TAP block during the same anesthetic * children in whom a TAP block is contraindicated, i.e. surgical scar or distorted anatomy at the site of injection * postoperative admission to the intensive care unit * children with a known allergy to bupivacaine * children with a history of chronic abdominal pain requiring opioid analgesics * children with known renal insufficiency * children with known impaired hepatic function * children with known impaired cardiac function * children known hypersensitivity to sodium metabisulfite
Healthy Volunteers: False
Sex: ALL
Minimum Age: 1 Month
Maximum Age: 6 Years
Study: NCT01243593
Study Brief:
Protocol Section: NCT01243593